CIK 0001533040 · Non-accelerated filer<br>Smaller reporting company
Phio Pharmaceuticals Corp.
Sign in to watch- Ticker
- PHIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 453215903
- Phone
- (508) 767-3861
- Business address
- 411 SWEDELAND ROAD, SUITE 23-1080, KING OF PRUSSIA, PA, 19406
- Former names
- RXi Pharmaceuticals Corp
- Open-market buys, last 90 days
- $104,806
- in 9 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$104,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 55 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-08-01 | Dispersyn Gerrit Chief Development Officer | Grant or award · Stock option (right to buy) | +16,000 | 16,000 | ||
| 2018-08-01 | Kontulis Caitlin Secretary & Dir. of Finance | Grant or award | +10,500 | 11,024 | ||
| 2018-08-01 | Kontulis Caitlin Secretary & Dir. of Finance | Grant or award · Stock option (right to buy) | +10,500 | 10,500 | ||
| 2017-10-02 | CAUWENBERGH GEERT President & CEO | Purchase | +2,700 | $0.44 | $1K | 135,283 |
| 2017-10-02 | CAUWENBERGH GEERT President & CEO | Purchase | +200 | $0.46 | $92 | 135,483 |
| 2017-10-02 | CAUWENBERGH GEERT President & CEO | Purchase | +7,100 | $0.45 | $3K | 142,583 |
| 2017-09-07 | Eliseev Alexey Chief Business Officer | Sale | −58,712 | $0.53 | $31K | 950,312 |
| 2017-09-06 | Eliseev Alexey Chief Business Officer | Sale | −91,907 | $0.54 | $49K | 1,009,024 |
| 2017-09-05 | Eliseev Alexey Chief Business Officer | Sale | −26,181 | $0.56 | $15K | 1,100,931 |
| 2017-09-01 | Eliseev Alexey Chief Business Officer | Sale | −23,200 | $0.57 | $13K | 1,127,112 |
| 2017-08-24 | CAUWENBERGH GEERT President & CEO | Purchase | +4,900 | $0.55 | $3K | 127,483 |
| 2017-08-24 | CAUWENBERGH GEERT President & CEO | Purchase | +4,361 | $0.55 | $2K | 131,844 |
| 2017-08-24 | CAUWENBERGH GEERT President & CEO | Purchase | +739 | $0.56 | $414 | 132,583 |
| 2017-06-23 | Dispersyn Gerrit Chief Development Officer | Purchase | +3,500 | $0.62 | $2K | 3,500 |
| 2017-06-22 | CAUWENBERGH GEERT President & CEO | Purchase | +5,000 | $0.63 | $3K | 117,583 |
| 2017-06-22 | CAUWENBERGH GEERT President & CEO | Purchase | +5,000 | $0.62 | $3K | 122,583 |
| 2017-06-09 | Eliseev Alexey Chief Business Officer | Conversion | +332,499 | 1,150,312 | ||
| 2017-06-09 | Eliseev Alexey Chief Business Officer | Conversion · Series C Convertible Preferred Stock, $0.0001 par value | −332,499 | 0 | ||
| 2017-06-06 | Freeman Jonathan E Director | Grant or award · Stock option (right to buy) | +3,500 | 3,500 | ||
| 2017-04-26 | CAUWENBERGH GEERT President & CEO | Purchase | +10,000 | $0.65 | $6K | 112,583 |
Page 8 of 13 · 258 trades